Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Five Prime Therapeutics, Inc. (FPRX)

« Back to company index

FPRX Chatter Timeline

Stock Ticker for FPRX

Most Active Tweeters for FPRX

UserTweets
@bulletin_en 8
@AmericanBanking 4
@StockMatusow 2
@ZolmaxNews 2
@bbnsnews 2

Recent Tweets for FPRX

OlympiaReport @OlympiaReport
Five Prime Therapeutics Inc $FPRX Given Consensus Recommendation of “Hold” by Brokerages https://t.co/PInInzgxnO
May 23rd 2019, 6:05pm
AmericanBanking @AmericanBanking
Five Prime Therapeutics Inc $FPRX Receives Consensus Recommendation of “Hold” from Analysts https://t.co/W8pOYiRiVt #stocks
May 23rd 2019, 6:05pm
bulletin_en @bulletin_en
Selecta Biosciences Inc. $FPRX Comparing side by side https://t.co/CYR9elO86Q
May 23rd 2019, 6:05pm
bbnsnews @bbnsnews
$5.01 Million in Sales Expected for Five Prime Therapeutics Inc $FPRX This Quarter https://t.co/nw9OneTGsG
May 21st 2019, 12:05am
bulletin_en @bulletin_en
Contrasting of Aimmune Therapeutics Inc. $FPRX https://t.co/A8lII56aHm
May 18th 2019, 2:05pm
WatchlistN @WatchlistN
Analysts Anticipate Five Prime Therapeutics Inc $FPRX Will Announce Earnings of -$0.89 Per Share https://t.co/65F1svVwF8
May 18th 2019, 11:05am
macondailynews @macondailynews
BidaskClub Lowers Five Prime Therapeutics $FPRX to Sell https://t.co/rjjBjk7WPC
May 18th 2019, 10:05am
dakotafinancial @dakotafinancial
BidaskClub Lowers Five Prime Therapeutics $FPRX to Sell https://t.co/SV126XmLH4
May 18th 2019, 10:05am
TranscriptDaily @TranscriptDaily
Five Prime Therapeutics $FPRX Downgraded by BidaskClub https://t.co/NgC9DlC16r
May 17th 2019, 11:05am
ZolmaxNews @ZolmaxNews
Five Prime Therapeutics $FPRX Downgraded by ValuEngine to “Sell” https://t.co/RGVxFlY6jZ
May 17th 2019, 11:05am
WKRBNews @WKRBNews
Five Prime Therapeutics $FPRX Downgraded by ValuEngine to “Sell” https://t.co/qBnzmrWFsd #markets
May 17th 2019, 11:05am
Board_Diversity @Board_Diversity
RT @talent4boards: Five Prime Thx welcomes Carol Schafer to #BoardOfDirectors @FivePrime_FPRX #WomenOnBoard $FPRX https://t.co/T6SmtAOpKj
May 17th 2019, 7:05am
talent4boards @talent4boards
Five Prime Thx welcomes Carol Schafer to #BoardOfDirectors @FivePrime_FPRX #WomenOnBoard $FPRX https://t.co/RoKTnQED1M
May 17th 2019, 7:05am
AmericanBanking @AmericanBanking
Five Prime Therapeutics Inc $FPRX Expected to Post Quarterly Sales of $5.01 Million https://t.co/6h4zIriM2w #stocks
May 17th 2019, 3:05am
InsiderAlertsIA @InsiderAlertsIA
$FPRX: New Insider Filing on EVP, Chief Scientific Officer BRYAN IRVING: https://t.co/UUhwJGBgsv
May 16th 2019, 6:05pm
StockTexts @StockTexts
$FPRX Five Prime Therapeutics, Inc. SEC Filing: Form 4 https://t.co/pBCuQGRA2V
May 16th 2019, 6:05pm
StockTexts @StockTexts
$FPRX Five Prime Therapeutics, Inc. SEC Filing: Form 4 https://t.co/EymLTwO99N
May 16th 2019, 6:05pm
fintel_io @fintel_io
$FPRX / Five Prime Therapeutics files form 8-K https://t.co/D23B03REJr
May 16th 2019, 4:05pm
1stOncology @1stOncology
#FivePrimeTherapeutics Announces #FPA150 Poster Presentation at #ASCO19 $FPRX https://t.co/1i6gF55e2G
May 16th 2019, 10:05am
bulletin_en @bulletin_en
Madrigal Pharmaceuticals Inc. $FPRX Comparing side by side https://t.co/rYRGPrdgFt
May 16th 2019, 12:05am
HottestStockNow @HottestStockNow
$FPRX Makes Strategic Move https://t.co/Jshsxlvyt1
May 15th 2019, 9:05pm
ProTradersNews @ProTradersNews
$FPRX: Five Prime Therapeutics Appoints Carol Schafer to its Board of …: https://t.co/BdcvY5VSJs
May 15th 2019, 6:05pm
StockNewsWires @StockNewsWires
$FPRX: Five Prime Therapeutics Announces FPA150 Poster Presentation at …: https://t.co/nDMPNNiMaa
May 15th 2019, 5:05pm
AmericanBanking @AmericanBanking
Five Prime Therapeutics Inc $FPRX Expected to Post Earnings of -$0.89 Per Share https://t.co/ZGVa6OmQqH #stocks
May 15th 2019, 10:05am
bulletin_en @bulletin_en
Reviewing Quanterix Corporation $FPRX's results https://t.co/J6JV6EJHMH
May 14th 2019, 5:05pm
bulletin_en @bulletin_en
Rafael Holdings Inc. $FPRX https://t.co/hsZAuwQXD5
May 13th 2019, 6:05pm
StockMatusow @StockMatusow
Disclosure - We have no position in $FPRX currently, long or short.
May 13th 2019, 4:05pm
StockMatusow @StockMatusow
Want a #biotech that's cash good with a legit shot to run again? See $FPRX - CD 80 - Legit gamble play but prob a b… https://t.co/XF44f5dQH9
May 13th 2019, 4:05pm
bulletin_en @bulletin_en
Contrasting of Vericel Corporation $FPRX https://t.co/35f4KQPRKD
May 11th 2019, 11:05am
bbnsnews @bbnsnews
Five Prime Therapeutics $FPRX Issues Quarterly Earnings Results, Beats Expectations By $0.05 EPS https://t.co/vP9OR7gZuW
May 11th 2019, 12:05am
bulletin_en @bulletin_en
Reviewing Fennec Pharmaceuticals Inc. $FPRX's results https://t.co/rWXkAAJDXO
May 10th 2019, 6:05pm
bulletin_en @bulletin_en
Reviewing Cyclacel Pharmaceuticals Inc. $FPRX's results https://t.co/6YuvbxtDwR
May 10th 2019, 5:05pm
BoardSecurities @BoardSecurities
$FPRX don’t mean to butt in as a result insane revenue growth few years back, went on some watch lists but astoun... https://t.co/d7jEZjqmS9
May 10th 2019, 2:05pm
ResearchPool @ResearchPool
$FPRX #Five Prime Therapeutics Inc Q1 Financials; FIGHT Enrollment Update: Increased Risk, Potentially Larger Opp.:… https://t.co/jKhgmcWpjI
May 10th 2019, 7:05am
AmericanBanking @AmericanBanking
Five Prime Therapeutics $FPRX Announces Earnings Results https://t.co/gSZe7TzeQr #stocks
May 10th 2019, 12:05am
ZolmaxNews @ZolmaxNews
Five Prime Therapeutics $FPRX Announces Quarterly Earnings Results, Beats Expectations By $0.05 EPS https://t.co/hje347ERR3
May 10th 2019, 12:05am
newswelldone @newswelldone
$FPRX: Five Prime Therapeutics, Inc. (FPRX) CEO Aron Knickerbocker on …: https://t.co/v9qI8h43pd
May 9th 2019, 11:05pm
SiteFocusHQ @SiteFocusHQ
$FPRX Qualitative Analysis of recent earnings identified Five Prime Therapeutics, Inc (NASDAQ: FPRX ) business focu… https://t.co/QGKnrVyGb1
May 9th 2019, 11:05pm
SeekingAlpha @SeekingAlpha
$FPRX - Five Prime Therapeutics, Inc. (FPRX) CEO Aron Knickerbocker on Q1 2019 Results - Earnings Call Transcript https://t.co/pznxb4QrcA
May 9th 2019, 11:05pm
EarningsAlley @EarningsAlley
Summary for the Five Prime Therapeutics, Inc. earnings call. $FPRX #earnings #FivePrimeTherapeuticsInc https://t.co/R0aa27ncrl
May 9th 2019, 11:05am
NewsToDesk @NewsToDesk
$FPRX: Five Prime Therapeutics (FPRX) Q1 2019 Earnings Call Transcript: https://t.co/7yWrVK0DU3
May 9th 2019, 11:05am
intercooleronli @intercooleronli
Head-To-Head Survey: Five Prime Therapeutics $FPRX vs. Celgene $CELG https://t.co/B6IGKQ5zL0 #investingnews
May 8th 2019, 8:05pm
ledgerzette @ledgerzette
Head-To-Head Survey: Five Prime Therapeutics $FPRX vs. Celgene $CELG https://t.co/S5DuIcqgwZ #stocks
May 8th 2019, 8:05pm
Estimize @Estimize
$FPRX beats the Estimize EPS Consensus by 2c and the Estimize Revenue Consensus by $0.45M. Reports FQ1 earnings of… https://t.co/KBii46oW8I
May 8th 2019, 4:05pm
MarketCurrents @MarketCurrents
$FPRX - Five Prime Therapeutics beats by $0.05, misses on revenue https://t.co/MYKgc7m4Nq
May 8th 2019, 4:05pm
StockTexts @StockTexts
$FPRX Five Prime Therapeutics, Inc. SEC Filing: Form 8-K https://t.co/rxOdEafx8f
May 8th 2019, 4:05pm
Estimize @Estimize
$FPRX reports after the close, Estimize Consensus +0.03 EPS and -0.63M Revs compared to WS - https://t.co/jpClYim5Hi
May 8th 2019, 11:05am
FinZTribune @FinZTribune
$-1.07 EPS Expected for Five Prime Therapeutics, Inc. $FPRX; Capital International Investors Has Increased Its Matt… https://t.co/Q9j8lERYQV
May 7th 2019, 3:05pm
surveyist @surveyist
RT @semodough: $FPRX – ASCO Abstract: Ph1 safety/PK data for FPA150 (anti-B7-H4) in advanced solid tumors on 5/15/19 $NCNA – ASCO Abs…
May 7th 2019, 7:05am
semodough @semodough
$FPRX – ASCO Abstract: Ph1 safety/PK data for FPA150 (anti-B7-H4) in advanced solid tumors on 5/15/19 $NCNA –… https://t.co/BzgEWedzMp
May 7th 2019, 6:05am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.